an Endocrine Society Thematic Issue
Read our special collection of journal articles, published in 2021–2023, focused on rare endocrine diseases! Curation of the collection was guided by Altmetric Attention Scores and subject relevance.
In Journal of the Endocrine Society, Fagundes and Almeida discuss the perioperative management of pheochromocytomas and sympathetic paragangliomas. In a pilot study, Rubin et al. document impaired cognition among hypoparathyroidism patients, with slower processing speed associated with lower serum calcium and high serum phosphate. In an Expert Endocrine Consult, Varlamov and colleagues discuss perioperative management of patients with Cushing disease.
In Endocrinology, Lee and associates review unexplored functions of sex hormones that might have therapeutic implications in glioblastoma multiforme cancer stem cells. Dey and coauthors discuss the role of estrogen receptor beta-1 in female “triple negative” breast cancer. Warde et al. report results pointing to an additional mechanism, lipid droplet breakdown leading to lipolysis, for mitotane’s toxicity to adrenocortical carcinoma.
In Endocrine Reviews, Brito and coauthors discuss mechanisms implicated in the etiology of central precocious puberty, stressing the delicate balance between excitatory and inhibitory influences on the pulsatile release of hypothalamic gonadotropin-releasing hormone. Gravholt and colleagues discuss new discoveries about the genetics of Turner syndrome. Lerario et al. analyze genetic insights that have transformed our understanding of adrenocortical carcinoma and allow its classification into subtypes with different characteristics.
In JCEM, Hawkes and coauthors report on two novel mutations in the parathyroid hormone gene that cause isolated hypoparathyroidism. Braun et al. revisit the Endocrine Society’s 2008 Clinical Practice Guideline recommendations on who should be screened for Cushing syndrome, concuding that the recommendations remained valid in 2022. And Yu and coauthors report on the presentation, management, and outcomes from 110 cases of urinary bladder paraganglioma, emphasizing the need for continued monitoring for metastases.
Published: March 2023
It can be difficult to keep up to date in the rapidly evolving and expanding world of endocrine science. We curate topical collections of research from across our journals, Endocrine Reviews, Endocrinology, Journal of the Endocrine Society, The Journal of Clinical Endocrinology & Metabolism, and JCEM Case Reports so that you can easily find and read recent, influential articles on the topics that interest you.
Selection in each Thematic Issue is guided by online metrics, including Altmetric Attention Scores, Featured Article designations, and identification of leading authors and key topics. Each month, we publish a new Thematic Issue online and work to highlight and promote endocrine science in the press, through email, on social media and across other distribution channels.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
